Compass Therapeutics (CMPX) Earnings Date & Reports

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CMPX is expected to report earnings to rise 2.75% to -12 cents per share on July 30

Compass Therapeutics CMPX Stock Earnings Reports

Q2'25

Est.

$-0.12

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.03

Q2'24

Est.

$-0.10

The last earnings report on May 08 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 253.39K shares outstanding, the current market capitalization sits at 290.39M.

View a ticker or compare two or three

Compare

CMPX